Irene Gomez-Navalpotro

Queen Square
Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Cognitive vergence and pupillary responses as functional oculomotor signatures to differentiate AT(N) biological profiles in older adults with mild cognitive impairment.

Cognitive vergence and pupillary responses as functional oculomotor signatures to differentiate AT(N) biological profiles in older adults with mild cognitive impairment.

Journal: GeroScience

Published: June 19, 2026

Plasma p-tau217 detects Alzheimer's disease co-pathology in cerebral amyloid angiopathy: Comparison to CSF biomarkers in the ANGMAR cohort.

Plasma p-tau217 detects Alzheimer's disease co-pathology in cerebral amyloid angiopathy: Comparison to CSF biomarkers in the ANGMAR cohort.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 22, 2026

CSF Biomarker Profile of Cerebral Amyloid Angiopathy: Diagnostic Performance and Imaging Correlates in a Hospital-Based Neurology Cohort.

CSF Biomarker Profile of Cerebral Amyloid Angiopathy: Diagnostic Performance and Imaging Correlates in a Hospital-Based Neurology Cohort.

Journal: European journal of neurology

Published: January 18, 2026

Expanding the clinical-radiological phenotype of SCA34 and its role in the differential diagnosis of the hot cross bun sign.

Expanding the clinical-radiological phenotype of SCA34 and its role in the differential diagnosis of the hot cross bun sign.

Journal: Journal of neurology

Published: July 21, 2025

A head-to-head comparison of plasma biomarkers to detect Alzheimer's disease in a memory clinic.

A head-to-head comparison of plasma biomarkers to detect Alzheimer's disease in a memory clinic.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: October 23, 2024

Isolated CSF RT-QuIC positivity associates with a less aggressive disease course and decreased levels of neuronal/glial damage biomarkers in patients with sporadic Creutzfeldt-Jakob disease.

Isolated CSF RT-QuIC positivity associates with a less aggressive disease course and decreased levels of neuronal/glial damage biomarkers in patients with sporadic Creutzfeldt-Jakob disease.

Journal: Journal of neurology

Published: September 19, 2024

Blood Biomarkers of Alzheimer's Disease and Cognition: A Literature Review.

Blood Biomarkers of Alzheimer's Disease and Cognition: A Literature Review.

Journal: Biomolecules

Published: October 31, 2023

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease.

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease.

Journal: Nature communications

Published: August 09, 2023

Risk of cognitive decline progression is associated to increased blood-brain-barrier permeability: A longitudinal study in a memory unit clinical cohort.

Risk of cognitive decline progression is associated to increased blood-brain-barrier permeability: A longitudinal study in a memory unit clinical cohort.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: May 11, 2023

NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-β and Tau Levels in the Continuum of Alzheimer's Disease.

NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-β and Tau Levels in the Continuum of Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: April 11, 2023

Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts.

Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts.

Journal: Alzheimer's research & therapy

Published: December 07, 2022

Blood-brain barrier integrity impacts the use of plasma amyloid-β as a proxy of brain amyloid-β pathology.

Blood-brain barrier integrity impacts the use of plasma amyloid-β as a proxy of brain amyloid-β pathology.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: September 30, 2022

Showing 1-12 of 35

Last Updated: 09/26/2026